Egypt

AI Citation Summary

• Country: Egypt
• Product line: Medical devices
• Regulator / source: Regulatory Maturity: Medium; in 2021, the Egyptian Drug Authority (EDA) integrated the functions of the former CAPA, becoming the unified medical product regulatory body; the regulatory framework is in the process of modernization, but procedures remain complex
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Legalisation, FX, and localisation - Consular legalisation, Arabic labels, FX availability, and customs timing affect real launch timelines - Treat authenticated documents, Arabic IFU / labels, spare parts, training, and payment terms as project critical paths
• Key fees: EDA product registration - EDA manages medical device registration, classification, technical review, import approvals, and post-market oversight - Verify the current MeDevice / EDA system, classification, document list, fees, samples, and deficiency requirements before filing
• Local requirement: Egypt medical device entry should be separated into five layers: EDA product registration, local importer / agent, UPA / public procurement, private hospitals and diagnostic groups, and document-legalisation / foreign-exchange / localisation execution. The registration certificate is usually held by the local importer or agent, so actual market access depends on that party's registration, importation, tendering, after-sales, and cash-collection capability.
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 107 million (2024), the second-most populous country in Africa and the largest population market in the MENA region
• Healthcare System: Predominantly public hospital system (under the Ministry of Health and Population, MOHP); private healthcare is growing rapidly; Universal Health Coverage (UHC) reform is progressing (the 2018 Universal Health Insurance Law is being implemented gradually); healthcare resources are concentrated in Cairo, Alexandria, and other major cities
• Market Characteristics: Government procurement is the primary channel for medical devices; price competition is intense; private clinics/hospitals are growing rapidly; high import dependence; government policy favors domestic manufacturing; historical foreign exchange controls have affected imports
• Regulatory Maturity: Medium; in 2021, the Egyptian Drug Authority (EDA) integrated the functions of the former CAPA, becoming the unified medical product regulatory body; the regulatory framework is in the process of modernization, but procedures remain complex

Market-Entry Logic

Egypt medical device entry should be separated into five layers: EDA product registration, local importer / agent, UPA / public procurement, private hospitals and diagnostic groups, and document-legalisation / foreign-exchange / localisation execution. The registration certificate is usually held by the local importer or agent, so actual market access depends on that party's registration, importation, tendering, after-sales, and cash-collection capability.

Layer	Market-entry meaning	Operating focus
EDA product registration	EDA manages medical device registration, classification, technical review, import approvals, and post-market oversight	Verify the current MeDevice / EDA system, classification, document list, fees, samples, and deficiency requirements before filing
Local importer / agent	Foreign manufacturers generally cannot apply directly in their own name; a licensed local importer executes registration and importation	Contracts should lock down certificate transfer, account control, import approvals, vigilance, recall, termination, and handover
UPA / public procurement	Public hospitals, university hospitals, and government projects are the main volume channels; UPA central procurement increases concentration and pricing pressure	Prepare tender eligibility, GS1 / traceability, supply continuity, pricing, and local inventory in parallel with registration
Private hospitals and diagnostic groups	Private hospitals, laboratories, and imaging centres in Cairo, Alexandria, and other large cities are better early-entry points for mid-to-high-end devices	Verify distributor hospital relationships, application support, financing options, and service capability
Legalisation, FX, and localisation	Consular legalisation, Arabic labels, FX availability, and customs timing affect real launch timelines	Treat authenticated documents, Arabic IFU / labels, spare parts, training, and payment terms as project critical paths

For foreign manufacturers, Egypt is not a market that can be entered quickly with CE / FDA technical files alone. CE / FDA supports technical review, but consular legalisation, local importer control, UPA procurement, pricing, and service capability are the larger variables behind launch speed and sales volume.

Main Players and Channel Map

Player type	Representative institutions / companies	Commercial meaning
Regulator	Egyptian Drug Authority (EDA)	Core entry point for device registration, import approvals, post-market safety, and local-agent responsibility
Public procurement and government channels	Unified Procurement Authority (UPA), MOHP, public hospitals, university hospitals, El Gomhoureya and other state-linked procurement / supply-chain channels	Core public-market, government-project, central-procurement, pricing, and supply-continuity gatekeepers
Local importers / distributors	Major medical equipment importers, laboratory-diagnostics distributors, and hospital engineering service providers	Execute registration, importation, tenders, installation, maintenance, training, and cash collection
Private hospital groups and diagnostic networks	Cairo / Alexandria private hospitals, Cleopatra Hospitals Group, Alameda Healthcare, Saudi German Hospital Egypt, diagnostic laboratory networks, and similar groups	Entry points for mid-to-high-end equipment, IVD, imaging, minimally invasive devices, and private specialty channels
Multinational device companies	Siemens Healthineers, GE HealthCare, Philips, Medtronic, Abbott, Roche Diagnostics, BD, and others	Premium equipment, IVD, consumables, clinical education, after-sales service, and large hospital projects
Local manufacturing / assembly ecosystem	Medical consumables, basic devices, packaging, service, and potential local assembly partners	Supports localisation, price competition, government-procurement preference, and regional export narratives

Channel due diligence should separately verify whether the partner can complete EDA registration and importation; whether it has UPA / public tender experience; whether it has engineers, spare parts, and training capability; and whether it can withstand government payment cycles and foreign-exchange risk. For installed equipment, service capability is usually more important than sales coverage alone.

Development Trends

1. EDA centralised regulation continues to advance: Since EDA integrated pharmaceuticals and healthcare-product regulation, device registration, importation, vigilance, and local-agent responsibilities are becoming more centralised, but system portals, forms, and execution details still need local-agent verification.
2. Central procurement and traceability raise compliance thresholds: UPA, GS1 / barcode traceability, and centralised procurement make supply-chain transparency, price, supply continuity, and local stock more important for public channels.
3. Local manufacturing and import-substitution pressure are increasing: Government policy favours local manufacturing, assembly, and technology transfer; basic consumables and standard equipment will face continued price competition.
4. Premium equipment depends on service and financing models: Imaging, ICU, OR, IVD, and laboratory equipment require installation, calibration, training, maintenance, spare parts, and sometimes financing / instalment structures.
5. Private healthcare provides mid-to-high-end entry points: Public channels determine scale, but private hospitals, diagnostic centres, and specialty groups are better early reference sites for innovative devices and premium equipment.
6. Foreign-exchange and payment-cycle risk remains commercial: USD/EUR import costs, Egyptian pound volatility, customs clearance, government payment cycles, and inventory strategy directly affect channel margin and supply stability.

Regulatory Authority

• Competent Authority: Egyptian Drug Authority (EDA), subordinate to the Ministry of Health and Population (MOHP); EDA's Medical Devices Registration Department handles specific registration matters
• Official Portal: https://edaegypt.gov.eg (primarily Arabic, with some English content); online submission: EDA online registration system / MeDevice-related services (recommended to operate through a local agent and verify the current entry point before filing)
• Key Regulations:
  • EDA Establishment Law (Law No. 151 of 2019 and its implementing regulations, 2021)
  • Medical Devices Registration Requirements (EDA medical device registration regulations)
  • Ministerial Decree 425/2019 (device classification and registration requirements)
  • Import Regulation (import permit regulations, coordinated with GASC/Customs)
  • GHTF/IMDRF framework as locally adapted and applied in Egypt

Device Classification System

Local Class	Risk Level	EU Equivalent	FDA Equivalent	Description
Class I	Low risk	EU Class I / FDA Class I	Basic registration; relatively simple document requirements
Class II	Low-medium risk	EU Class IIa / FDA Class II	Standard registration; Technical File required
Class III	Medium-high risk	EU Class IIb / FDA Class II–III	Full technical review; relatively strong clinical evidence required
Class IV	High risk	EU Class III / FDA Class III	Most rigorous review; complete clinical data required

Classification follows GHTF classification principles (SG1 N15 and other guidance documents); some product categories have Egypt-specific classification interpretations.

Registration Pathways

During the limited-time free period, sign in or register to view the complete medical device country report.